These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32609610)

  • 1. Olanzapine versus Metoclopramide for Treatment of Nausea and Vomiting in Advanced Cancer Patients with Incomplete Malignant Bowel Obstruction.
    Kaneishi K; Imai K; Nishimura K; Sakurai N; Kohara H; Ishiki H; Kanai Y; Oyamada S; Yamaguchi T; Morita T; Iwase S
    J Palliat Med; 2020 Jul; 23(7):880-881. PubMed ID: 32609610
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: Olanzapine: Sancho Panza for clinicians who care for patients with advanced cancer.
    Harder S; Groenvold M; Herrstedt J
    Support Care Cancer; 2020 Apr; 28(4):1539. PubMed ID: 31919666
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction.
    Kaneishi K; Kawabata M; Morita T
    J Pain Symptom Manage; 2012 Oct; 44(4):604-7. PubMed ID: 22771132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The final assessment of a randomized double-blind comparative study of ondansetron vs. metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation.
    Clin Oncol (R Coll Radiol); 1991 Jul; 3(4):241-2. PubMed ID: 1834162
    [No Abstract]   [Full Text] [Related]  

  • 5. Nausea and vomiting in advanced cancer.
    Ang SK; Shoemaker LK; Davis MP
    Am J Hosp Palliat Care; 2010 May; 27(3):219-25. PubMed ID: 20197557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update.
    Davis M; Hui D; Davies A; Ripamonti C; Capela A; DeFeo G; Del Fabbro E; Bruera E
    Support Care Cancer; 2021 Dec; 29(12):8089-8096. PubMed ID: 34390398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting.
    Ljutić D; Perković D; Rumboldt Z; Bagatin J; Hozo I; Pivac N
    Kidney Blood Press Res; 2002; 25(1):61-4. PubMed ID: 11834879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced vomiting in children: An open-label, randomized phase 3 trial.
    Radhakrishnan V; Pai V; Rajaraman S; Mehra N; Ganesan T; Dhanushkodi M; Perumal Kalaiyarasi J; Rajan AK; Selvarajan G; Ranganathan R; Karunakaran P; Sagar TG
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28532. PubMed ID: 32568452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of granisetron, droperidol, and metoclopramide in the treatment of established nausea and vomiting after breast surgery: a double-blind, randomized, controlled trial.
    Fujii Y; Tanaka H; Kawasaki T
    Clin Ther; 2003 Apr; 25(4):1142-9. PubMed ID: 12809962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer.
    Mystakidou K; Befon S; Liossi C; Vlachos L
    Cancer; 1998 Sep; 83(6):1214-23. PubMed ID: 9740088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy].
    Budach V; Krüger K
    Fortschr Med; 1983 Oct; 101(39):1792-4. PubMed ID: 6642386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
    Srivastava M; Brito-Dellan N; Davis MP; Leach M; Lagman R
    J Pain Symptom Manage; 2003 Jun; 25(6):578-82. PubMed ID: 12782438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Benefits of Olanzapine in Palliating Symptoms.
    Davis MP; Sanger GJ
    Curr Treat Options Oncol; 2020 Nov; 22(1):5. PubMed ID: 33244634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granisetron, droperidol, and metoclopramide for the treatment of established postoperative nausea and vomiting in women undergoing gynecologic surgery.
    Fujii Y; Tanaka H; Somekawa Y
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):13-6. PubMed ID: 10649150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children.
    Van Eygen M; Dhondt F; Heck E; Ameryckx L; Van Ravensteyn H
    Postgrad Med J; 1979; 55 Suppl 1():36-9. PubMed ID: 382153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nausea and vomiting in advanced cancer.
    Davis MP; Walsh D
    Support Care Cancer; 2000 Nov; 8(6):444-52. PubMed ID: 11094988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer.
    Bruera E; Belzile M; Neumann C; Harsanyi Z; Babul N; Darke A
    J Pain Symptom Manage; 2000 Jun; 19(6):427-35. PubMed ID: 10908823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen.
    Bruera E; Seifert L; Watanabe S; Babul N; Darke A; Harsanyi Z; Suarez-Almazor M
    J Pain Symptom Manage; 1996 Mar; 11(3):147-53. PubMed ID: 8851371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of nausea: prevalence, etiology, and treatment in patients with advanced cancer not receiving antineoplastic treatment.
    Harder S; Herrstedt J; Isaksen J; Neergaard MA; Frandsen K; Sigaard J; Mondrup L; Jespersen BA; Groenvold M
    Support Care Cancer; 2019 Aug; 27(8):3071-3080. PubMed ID: 30610434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MASCC antiemetics in advanced cancer updated guideline.
    Davis M; Hui D; Davies A; Ripamonti C; Capela A; DeFeo G; Del Fabbro E; Bruera E
    Support Care Cancer; 2021 Dec; 29(12):8097-8107. PubMed ID: 34398289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.